Skip to main content
GoodMoatv1.3
Sign in
SMLR logo

SMLR

CompareEarnings: Mar 2, 2026

Semler Scientific Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Devices

Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Current Price

$20.33

+0.00%

GoodMoat Value

$128.87

533.9% undervalued
Profile
Valuation (TTM)
Market Cap$300.98M
P/E6.23
EV—
P/B1.30
Shares Out14.80M
P/Sales8.14
Revenue$36.96M
EV/EBITDA6.15

Semler Scientific Inc (SMLR) Company Profile

SMLR Company Information

Semler Scientific, Inc. is the second U. S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases.

By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin.

In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc.

develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U. S.

Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

Country

California, USA

SMLR Key Officers

Key officers data coming soon

SMLR Company Profile

Semler Scientific Inc (SMLR) is a Healthcare company in the Medical Devices industry. It trades on NASDAQ. The company is based in California, USA.

Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Market cap is $300.98M. There are 14.8M shares outstanding.

See the full Semler Scientific Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if SMLR is a good investment.